案例 Products
Hot Products / 相关推荐
2018 - 03 - 05
Immuno-Oncology IntroductionImmuno-therapy has now been representing a significant paradigm shift in cancer treatment after the promising clinical data from the immune-checkpoint m...
2018 - 03 - 02
Gastric Carcinoma     Introduction     Gastric carcinoma remains a common disease with a dismal prognosis. It represents the fourth most frequent mali...
2018 - 03 - 02
With 655,000 deaths worldwide per year, colorectal cancer (CRC) is the second leading cause of cancer-related death in Western society and the incidence and mortality are increasing dramatically in th...
2018 - 03 - 01
Asthma is a chronic inflammatory disorder of the airways in which many infiltrating cells (such as mast cells, eosinophils, T lymphocytes, macrophages, neutrophils, and epithelial cells) and cellular ...
产品名称: Immuno-Oncology
型号:
2018 / 03 / 05
Immuno-Oncology IntroductionImmuno-therapy has now been representing a significant paradigm shift in cancer treatment after the promising clinical data from the immune-checkpoint modulators. Profiling anti-cancer drug candidates with clinical relevant animal models provides fundamental information for oncology research and development. PharmaLegacy offers comprehensive oncology and immuno-oncology drug discovery platform which includes in vi...
产品名称: Gastric Carcinoma
型号:
2018 / 03 / 02
Gastric Carcinoma     Introduction     Gastric carcinoma remains a common disease with a dismal prognosis. It represents the fourth most frequent malignancy and second leading cause of caner-related death worldwide. A significant geographic variation exists with high-risk areas including Japan, Central and South America and Eastern Asia. Despite the major improvements in diagnosis and treatment, less than 20% of patients survive to 5 years. Chemo...
产品名称: Colorectal Carcinoma
型号:
2018 / 03 / 02
With 655,000 deaths worldwide per year, colorectal cancer (CRC) is the second leading cause of cancer-related death in Western society and the incidence and mortality are increasing dramatically in the rest of the world. Approximately 25% of  patients have a family history of CRC, suggesting a genetic contribution, common exposures among family members or a combination of both. Other risk factors for CRC include diet, use of non-steroidal anti-inflammatory drugs (NSAIDs), postmenopausal hor...
2018 / 01 / 31
Human Cancer Cell Selection PanelApplication:Human cancer cell selection panel serves for anti-cancer drug discovery. To evaluate the potential cytotoxicity and growth-inhibition effects of the test articles against multi-type tumors in a quick and efficient way. More than 60 human cancer cells can be screened by cell proliferation/cytotoxicity assay, covering Liver, Lung, Breast, Lymphoma, Colon, Melanoma, Leukemia, Myeloma tumors. After the in vitro screen, the most sensitive cancer cell lines...
2018 / 01 / 31
Hepatocellular Carcinoma            Introduction          Aflatoxin or chronic infection with hepatitis B and C virus is the predominant risk factor for HCC in Southeast Asia and Africa,     while chronic infection with hepatitis C virus and hepatic cirrhosis (mostly alcoholism) are the predominant risk factors for HCC in Western countries and Japan.  &...
Copyright ©2013 - 2018 
澎立生物医药技术(上海)有限公司
X
1

QQ设置

3

SKYPE 设置

4

阿里旺旺设置

5

电话号码管理

  • +86-21-6100-2270
6

二维码管理

等待加载动态数据...

等待加载动态数据...

回到顶部
展开